0001250853-18-000073.txt : 20180509 0001250853-18-000073.hdr.sgml : 20180509 20180509185933 ACCESSION NUMBER: 0001250853-18-000073 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180508 FILED AS OF DATE: 20180509 DATE AS OF CHANGE: 20180509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EDDLEMAN ROY T CENTRAL INDEX KEY: 0001270264 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 18820029 MAIL ADDRESS: STREET 1: 110 W. GEORGE BURNS ROAD STREET 2: SUITE D-4018 CITY: LOS ANGELES STATE: CA ZIP: 90048 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-05-08 0 0000730272 REPLIGEN CORP RGEN 0001270264 EDDLEMAN ROY T C/O TROYGOULD PC 1801 CENTURY PARK E., 16TH FLOOR LOS ANGELES CA 90067 0 0 1 0 Common Stock 2018-05-08 4 S 0 49227 40.77 D 430773 I As trustee Common Stock 2018-05-08 4 S 0 25000 40.66 D 875000 I As trustee Common Stock 2018-05-09 4 S 0 20773 40.52 D 410000 I As trustee Common Stock 2018-05-09 4 S 0 25000 40.37 D 850000 I As trustee Common Stock 357518 D Common Stock 3044826 I As trustee The price is a weighted-average price. The shares were sold in multiple transactions at prices ranging from $40.5515 to $41.0078, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the price ranges set forth in this footnote (1) and in footnote (3) to this Form 4. The shares shown are held, of record, by a charitable remainder unitrust of which the reporting person is the sole trustee and, as such, has investment and voting control over such shares, and is a lifetime beneficiary. The reporting person disclaims as beneficial ownership of the shares except to the extent of his pecuniary interest therein. The price is a weighted-average price. The shares were sold in multiple transactions at prices ranging from $40.5607 to $41.0107, inclusive. The shares shown are held, of record, by a separate charitable remainder unitrust of which the reporting person is the sole trustee and, as such, has investment and voting control over such shares, and is a lifetime beneficiary. The reporting person disclaims as beneficial ownership of the shares except to the extent of his pecuniary interest therein. The price is a weighted-average price. The shares were sold in multiple transactions at prices ranging from $40.2401 to $40.70, inclusive. The price is a weighted-average price. The shares were sold in multiple transactions at prices ranging from $40.2102 to $40.6022, inclusive. The shares are held for the benefit of the reporting person in a 15-month escrow account established in connection with the acquisition of Spectrum, Inc. on August 1, 2017 and are subject to potential indemnification claims of the issuer relating to the acquisition. The shares are held of record by the Roy T. Eddleman Living Trust UAD 8-7-2000, of which the reporting person is the sole trustee, and as such, has investment and voting control over such shares. /s/ Istvan Benko, Attorney-in-fact for Roy T. Eddleman 2018-05-09